Typicality: | 0.623 |
Saliency: | 0.592 |
in december | 14 | temporal |
for human testing | 12 | purpose |
for a new use | 11 | purpose |
drug → receive → fda approval | 85 |
drug → win → fda approval | 38 |
drug → gain → fda approval | 35 |
drug → received → fda approval | 24 |
drug → get → fda approval | 22 |
drug → have → fda approval | 18 |
drug → be received → fda approval | 6 |
drug → be granted → fda approval | 6 |
drug → obtain → fda approval | 5 |
drug → get → an fda approval | 4 |
drug → gained → fda approval | 3 |
drug → earn → fda approval | 3 |
drug → be given → fda approval | 3 |
drug → garner → fda approval | 3 |
negative | neutral | positive |
0.148 | 0.543 | 0.309 |
Raw frequency | 255 |
Normalized frequency | 0.592 |
Modifier score | 0.871 |
Perplexity | 248.352 |